John Hopper is the Founding Chairman of the GI Cancers Alliance, President of the Fibrolamellar Cancer Foundation and Founding Co-Chair National Organization Rare Disorders (NORD) Rare Cancer Coalition. In 2020, the Chan Zuckerberg Initiative recognized John’s efforts in oncology by awarding him and his team their first multi-year rare cancer research grant. Prior to his focus on health care foundations, John created and led multibillion-dollar revenue centers as well as start-ups and turn-arounds across numerous industry verticals with an emphasis in health/wellness, digital/interactive, consumer goods, environment, and technology. John launched profitable divisions and products for such companies as the WPP Group, IPG, Unilever, P&G, and Publicis and spearheaded complex international cross-discipline management teams. CNN’s Larry King was perhaps one of Hopper’s most interesting clients as he was tasked to co-lead the Larry King Cardiac Foundation for seven years. John has held various board positions within digital companies as well as co-founding wellness venture capital and renewable energy mobilization firms. His experience also includes: Adjunct Professor, NYU Stern Graduate School of Business, US Department of Defense – Pancreatic Cancer Research Advisory Board, State of Connecticut Business Health Council- Office of Secretary of State, University of Connecticut – Environmental Health Academic Internship leader, to name just a few.
Hopper is a graduate of the College of the Holy Cross, and the Unilever/Oxford Executive MBA program. The proud father of Jonathan, Allyson, and Katey, John has personally been touched by pancreatic cancer, as his father, Dr. Paul Hopper, Ph.D., and uncle Donald J. Hopper lost their lives to this horrific disease.